November 2018
Table of Contents

Funding Opportunities

Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS, Second Wave) (UG3/UH3 Clinical Trial Required)


Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)



View a full list of current funding opportunities.

Highlighted positions related to cancer for which VCU is currently hiring. View the full list.




Program Co-Leader, Cancer Molecular Genetics (F36090)


Surgical Oncology Division Chair (F59750)

Shared Resource Spotlight
Lipidomics and Metabolomics Core

The Lipidomics and Metabolomics Core received a rare and coveted "outstanding" assessment at Massey's last NCI Cancer Center Support Grant review and is therefore acknowledged as a scientific resource of national significance. The VA Higher Education Equipment Trust Fund has awarded funds to acquire a ThermoFisher Q Exactive HF Hybrid Quadrupole/Orbitrap Mass Spectrometry system. This instrument will allow for sophisticated untargeted lipidomics and untargeted general metabolomics workflows, building on the core's well-established expertise in the realm of targeted lipidomics.


For more information, contact resource director Ashley Cowart, Ph.D., at 827.7910, or operational manager Jeremy Allegood, Ph.D., at 827.9909 or visit the Massey website.

Leaders' Update Update 
A message from Devanand Sarkar, associate director for education and training

Dear colleagues,

I am pleased to share several updates on education and training programs at Massey Cancer Center. This message continues with more on:
  • The new RAM Opportunities Program
  • The NCI-funded T32 postdoctoral training program in CPC
  • The Cancer and Molecular Medicine Ph.D. concentration
  • Massey's cancer research postdoctoral fellowship
Research HighlightsHighlights
Manjili discovers new form of immune cell with implications for treating cancer
Masoud Manjili, D.V.M., Ph.D.
Cancer Cell Signaling member
Research led by Masoud Manjili, and published in the Journal of Leukocyte Biology, discovered that an increased number of a unique type of antigen presenting cells, Gr1-/lowCD11b-/low cells, correlated to prolonged survival in mouse models of metastatic breast cancer. The scientists are hopeful that their findings may guide the treatment of cancer and other diseases.

Center News Center1
Massey physicians receive Best Bedside Manner Awards

Massey physicians were again recognized by
Our Health Richmond magazine with Best Bedside Manner Awards for the compassionate care, empathy and attentiveness they provide to their patients. Over 30,000 local individuals voted for medical providers in more than 80 medical specialties.

Member Showcase MemberShowcase

Lister studies genetic mutations in zebrafish in an effort to treat or prevent melanoma

Cancer Molecular Genetics member
James Lister joined Massey as a member of the Cancer Molecular Genetics research program in 2018. He studies proteins that are linked to cancer development in an effort to inform the biology and treatment of melanoma and other genetic diseases. Lister is an assistant professor in the Department of Human and Molecular Genetics at the VCU School of Medicine.

Researcher Recognition Recognition
Krist is sixth faculty member at VCU to be elected to the National Academy of Medicine

Cancer Prevention and Control member
Alex Krist has been elected as a member of the National Academy of Medicine, considered one of the highest honors in the fields of medicine and health. As a member, Krist joins the ranks of five other VCU School of Medicine colleagues including fellow Massey researcher Steven Woolf. 

Special Announcement Recognition
NIH Training Grant Data Tracking - Help Needed from Massey Members

As part of Massey's strategic priorities, we need to focus on the submission of training grant applications. Training grants are vital in supporting the education, training and mentoring activities at Massey, and having funded training grants will help strengthen our quest for comprehensive designation in our next competitive CCSG application. In an effort to gather the information needed, we have created an email address ( to which we are asking you to forward any inquiries you receive from postdoc applicants. Whether you receive an informal or informal inquiry, we ask that you forward it along with any attached material (eg, CV, biosketch, research interest description). You will still need to respond to any inquiries you receive as MCC administration will only be tracking the inquiries, but will not be responding to them.

EventsUpcoming Events

MCC Research Seminar
November 28, 2018: Lopa Mishra, M.D., of George Washington University, will lead a seminar on targeting TGF-Beta in liver and GI cancers from
4-5PM in GRL-131.

Ukrop's Monument Avenue 10k

For a full listing of events, 

mediaMassey in the Media

NewsTop Cancer News
Share with us your research, awards and accomplishments!
Submit your news to Blake Belden at or (804) 628-4578.

Archived newsletters can be found here:
  Connect with us!
Join Massey's online communities.
Like us on Facebook
Follow us on Twitter
View our videos on YouTube